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Abstract: The interaction of the important but often overdosed local anesthetic bupivacaine, 
its structural analogs 2,6-dimethylaniline, and N-methyl-2,6-dimethylacetanilide, and cocaine, 
with several electron deﬁ  cient aromatic moieties were studied primarily by proton NMR and 
UV-visible spectroscopy. In solution, the anesthetic, its analogs and cocaine are electron donors 
and form π-π charge transfer complexes with strong aromatic acceptors, as monitored by the 
upﬁ  eld changes induced in the NMR chemical shifts (δ) and red-shifted UV-vis wavelength 
(λmax) absorbance of the acceptors. The equilibrium binding constant, K, was determined from 
the 1H NMR charge transfer induced chemical shift changes and used to calculate the free 
energy (ΔG) for complex formation of three acceptor-donor pairs. HPLC results indicate that 
the concentrations of free bupivacaine, its analogs and of cocaine are reduced from solution 
via binding to aromatic-functionalized silica.
Keywords: bupivacaine, cocaine, charge transfer complex, NMR, drug overdose, selective 
toxin removal
Introduction
Overdoses of many natural and synthetic chemicals are a problem that must be solved 
in tandem with the continual development of drugs designed for human comfort and 
longevity (as well as those intended to inﬂ  ict harm), but which become toxic when 
taken in excess. Exposure to excess amounts of some therapeutics can be reversed if 
general or selective antidotes are available. In emergency situations, it is critical that 
a patient be quickly stabilized and the availability of an appropriate antidote may be 
the only pathway to remediation. Thus, it is crucial that materials for use in selectively 
reversing the adverse effects of overdosed toxins be readily available. These toxins 
not only include some common street drugs but also prescription therapeutics that 
can cause death by cardiac arrest if not quickly removed. Three such therapeutics are 
amiodarone (anti-arrhythmic), amitriptyline (antidepressant), and bupivacaine (local 
anesthetic), which cause signiﬁ  cant morbidity and mortality in humans annually, and 
for which no speciﬁ  c pharmaceutical antidotes have been developed to date. Technolo-
gies based on injectable nanoparticles for in vivo remediation of these therapeutics 
are currently in development in the author’s laboratories (Partch et al 2003; Powell 
2004; Lee et al 2005).
The development of a viable toxin-removal technology has been advanced by the 
fundamental information obtained in the present work (Figure 1) for the rapid binding of 
bupivacaine (1) and its analogs 2,6-dimethylaniline and 2,6-dimethylacetanilde, 2, and 3, 
respectively, and of cocaine, 4 by the acceptor molecules. The structures 1, 2, 3 and 4 show 
that the molecules are lipophilic in nature, a characteristic common to toxic molecules. 1, 2 
and 3 include a benzene ring with two methyl and a nitrogen electron-donating groups, International Journal of Nanomedicine 2007:2(3) 450
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making this portion of the molecules π-electron rich, and 
hence strong π-donors. The aromatic ring of cocaine, 4, also 
has weak π-donor capability when complexed with a strong 
π-acceptor like the one employed in this work. The strategy 
utilized for the selective removal of excess bupivacaine and 
cocaine from solution in this study involves charge transfer 
complex formation of the π-π type through aromatic-aromatic 
interaction, based on the assumption that dinitrobenzoyl groups 
possessing less π-electron density would not only bind with 
the more π-electron rich bupivacaine and cocaine but would 
also reduce their toxic effects. The LD50 of bupivacaine is 
7.8 mg kg–1 SC. The effectiveness of this approach is based 
on the fact that only free, unbound molecules in the blood 
possess toxicity and that they lose toxicity once bound to or 
conjugated with another moiety (Wilkinson 2001).
Charge transfer complexation has been a well-known 
interaction since the early discoveries made by Benesi and 
Hildebrand (1949), through the pioneering work of Briegleb 
(1961) and the valence-bond, and molecular orbital descrip-
tions put forth by Mulliken (1952), and Dewar and Lepley 
(1961), respectively. Aromatic interactions are driven by the 
noncovalent ie, hydrophobic, electrostatic, and hydrogen 
bonding forces. Although they occur with relatively small 
binding energies in the range 2–5 kcal/mol, aromatic-
aromatic types of electrostatic interaction are one of the 
principal noncovalent forces governing the fundamental 
process of molecular recognition between molecules in 
biology and chemistry (Slifkin 1981; Hunter 1994; Adams 
et al 2001; Chujo and Tamaki 2001; Sinnokrot et al 2002). 
For example, it inﬂ  uences the structures of proteins, DNA, 
host-guest complexes and self-assembled supramolecular 
architectures (Boal and Rotaldo 2000). The range and 
signiﬁ  cance of charge transfer complex formation in chemi-
cal and biological recognition has been illustrated in a recent 
review (Meyer et al 2003).
Nuclear magnetic resonance has proven valuable for 
evaluating the binding of antimalarials with heme species 
(Constantinidis and Satterlee 1988a, 1988b), the use of 
paraquat to probe for certain aspects of polypeptide and 
protein conformations (Verhoeven et al 1974), and the charge 
transfer complex formation between trinitrobenzene and a 
structural analog of the important neurochemical dopamine 
(Dust 1992). Dust’s results suggested to us that π-π charge 
transfer complex formation might be a means by which selec-
tive reversal of the lethal effects of overdosed bupivacaine 
could be achieved. The method of charge transfer complex 
formation has not previously been investigated in the context 
of in vivo toxin removal.
In the present report, the title compound, its analogs 2 and 
3, and cocaine, 4, were studied to demonstrate the feasibility 
of π-π charge transfer complex formation with π-electron 
deﬁ  cient aromatic rings. The formation of a π-π charge trans-
fer complex was evaluated by the changes observed in the 
NMR chemical shifts and UV-vis wavelength of maximum 
absorbance induced in the aromatic acceptor upon addition 
of excess amounts of the drugs or analogs. The goal is to 
employ the concept to develop a common antidote for in vivo 
application to alleviate overdose toxicity.
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Experimental
Materials
The following were obtained from Sigma-Aldrich chemi-
cal company, Milwaukee, WI, and used as received: 
1,3,5-trinitrobenzene, 1,3,5-tricyanobenzene, 1,3-bis(triﬂ  u
oromethyl)benzene, 2,4- and 3,5-dinitrobenzoyl chloride, 
2,4-dinitrobenzenesulfonyl chloride, 3,5-dinitrobenzyl 
alcohol, ethylamine, 2,4-, 2,6- and 3,5-dimethylaniline, 
3,4-dimethoxytoluene, bupivacaine hydrochloride, tetrahy-
drofuran (THF), acetonitrile (HPLC grade), and chloroform-d 
(CDCl3) and acetonitrile-d3 (CD3CN), the latter two solvents 
containing 0.03% v/v TMS. Deuterated water (D2O) was 
obtained from ACROS, New Jersey. Solvent grade acetoni-
trile, acetyl chloride, and diethyl ether were obtained from 
J.T. Baker, Inc., New Jersey. Methylamine, 40% (w/w) 
aqueous solution, and pentafluorbenzoyl chloride were 
obtained from Lancaster Synthesis, New Hampshire. Reagent 
grade acetone was obtained from Pharmco Products, Inc., 
Connecticut. Nine inch long, 5 mm thin wall NMR sample 
tubes (Cat. No. 528-PP-9) were obtained from Wilmad Glass 
Company, Inc., Buena, NJ.
Materials not commercially available to serve as 
electron acceptors and donors were synthesized. In lieu of 
1,3,5-trinitrobenzene, which exhibits a greater π-electron 
acceptor effect, analogs with the aromatic rings substituted 
with two nitro groups and a carboxamide or sulfonamide 
group were studied. The amido functionality provides a 
handle that can be utilized for subsequent attachment of the 
π receptor to injectable carrier nanoparticles. One recep-
tor containing a pentaﬂ  uorophenyl group was studied for 
variation. 2,6-Dimethylaniline (commercially available) 
and its acetamide analog, which was synthesized, served as 
models for the electron-donating portion of the bupivacaine 
molecule. The syntheses of these molecules are presented 
in the following section. In the presentation of the NMR 
results, s, d, t, q, m, and br are singlet, doublet, triplet, quartet, 
multiplet and broad peak characteristics, respectively. Broad 
signals are associated with amido hydrogens.
Syntheses of Pi acceptors and donor
N-Methyl-3,5-dinitrobenzamide (DNB)
3,5-Dinitrobenzoyl chloride (5.0 g, 21.3 mmol) was dissolved 
in 20 mL of ether in a 100 mL round-bottom ﬂ  ask equipped 
with a stir bar. Aqueous methylamine (3.3 g, 42.5 mmol) was 
added drop-wise through a funnel with stirring of the benzoyl 
chloride solution. After all the amine had been added, the 
reaction was allowed to proceed 12 hours. The precipitate 
was ﬁ  ltered and washed with water. The water washing was 
extracted with ﬁ  ve 50 mL portions of ether. The ether extracts 
were combined and dried with anhydrous sodium sulfate, 
which was removed by ﬁ  ltration. The ether was removed by 
roto-evaporation. The residue and original precipitate were 
dried in vacuo at room temperature overnight. Both solids 
were conﬁ  rmed to be the same material by melting point and 
NMR and were combined and recrystallized from toluene 
to give the product in 87% yield (4.18 g): mp 146–147 °C; 
NMR (CDCl3): δ 9.16 (t, 1H), 8.96 (d, 2H), 6.48 (s, br, 1H), 
3.12 (d, 3H).
N-Ethyl-2,4-dinitrobenzamide (EDNB)
This compound was synthesized by a similar procedure 
as used for DNB, with the corresponding reagents 
2,4-dinitrobenzoyl chloride (5.0 g, 21.3 mmol) and ethyl-
amine (1.98 g, 42.6 mmol) dissolved in 20 and 10 mL ether, 
respectively, and the amine added to the chloride. NMR 
(CDCl3): δ 8.92 (s, 1H), 8.53 (d, 1H), 7.75 (d, 1H), 5.85 
(s, br, 1H), 3.57 (m, 2H), 1.31 (t, 3H).
N-Ethyl-2,4-dinitrobenzenesulfonamide (EDNS)
EDNS was synthesized by a procedure similar to that used 
for DNB with the corresponding reagents 2,4-dinitrobenzene-
sulfonyl chloride (2.66 g) and ethylamine (0.9 g) dissolved 
in 20 and 10 mL of ether, respectively, and the amine added 
to the chloride. This solution was reﬂ  uxed overnight. The 
resulting solids were ﬁ  ltered on a Buchner funnel and washed 
consecutively with ether and water then dried at room tem-
perature in vacuo overnight to give the product: mp 95–97 °C; 
NMR (CDCl3) δ 8.68 (s, 1H), 8.56 (d, 1H), 8.38 (d, 1H), 5.27 
(s, br, 1H), 3.25 (m, 2H), 1.21 (t, 3H).
N-Methyl-pentaﬂ  uorobenzamide(MPFB)
Aqueous methylamine (5.62 g) was added to 50 mL of ether 
in a round bottom ﬂ  ask with magnetic stirring. Pentaﬂ  uoro-
benzoyl chloride (5 mL) was dripped into the reaction vessel 
and the reaction allowed to proceed at room temperature 
overnight. The contents were then transferred to 125 mL 
separatory funnel, the water layer was removed and the 
remaining ether layer was washed with ﬁ  ve 10 mL portions 
of water (ether became cloudy after the second washing). 
The ether layer was dried with anhydrous magnesium sul-
fate, which was removed by ﬁ  ltration. Evaporation of the 
ether yielded a solid, mp 85–95 °C. The solid was dissolved 
in a minimal amount of methylene chloride and extracted 
with two 15 mL portions of water. The organic layer was 
dried with magnesium sulfate, ﬁ  ltered, and the methylene 
chloride removed. The remaining solid was dried in vacuo International Journal of Nanomedicine 2007:2(3) 452
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at room temperature overnight and recyrstallized from 
toluene to give the product in 55.58% yield (4.53 g): mp 
98–99 °C; 1H NMR (CDCl3) δ 6.2 (s, br, 1H), 3.02–3.03 
(d, 3H); 19F NMR in CDCl3 showed all three sets of ﬂ  uorines 
resonating at δ values of –140.2859 ppm, –150.4915 ppm, 
and –159.8655 ppm.
2,6-Dimethylacetanilide (DMAc)
2,6-Dimethylaniline (5 g) was dissolved in 20 mL of ether 
in a round bottom ﬂ  ask. A solution of 10% (w/w) NaOH 
(15 mL) was added, then 3 mL of acetyl chloride dissolved 
in 15 mL ether were slowly (∼20 minutes) dripped into the 
ﬂ  ask and the reaction allowed to take place for 10 hours and 
resulted in the formation of a precipitate.
The solid was ﬁ  ltered on a Buchner funnel and washed 
with ether. Recrystallization from toluene gave the product 
in 70% yield (4.71 g): mp 181–182 °C (lit. 182–184 °C 
(Aldrich)); NMR (CDCl3) δ 7.08 (m, 3H), 6.70 (s, br, 1H), 
2.23 (t, 6H), 1.74 (s, 3H).
Silica functionalized with 3,5-dinitrobenzoyl groups 
(SiDNB)
Silica (12 nm diameter, 100 mL, 20 wt% in acetone, 
Nissan Chemical Co.) was placed in a ﬂ  ask and stirred 
while a solution of 5 g (0.022 mole) 3,5-dinitrobenzoyl 
chloride dissolved in 50 mL dry THF was added dropwise. 
The mixture was reﬂ  uxed for 12 hours during which time 
the color turned from colorless to light yellow to brown. All 
solvent was evaporated and the tan solid was treated with 
200 mL ethanol, then aqueous sodium bicarbonate and the 
precipitated solid product collected by centrifugation at 
12,000 rpm and washed with ethanol and dried at 110 °C 
under vacuum to give 7.5 g material; density, 1.809 g mL–1; 
TEM, 15–20 nm particles and aggregates; TGA 3.6 wt% 
organics; IR (cm–1), 3095, 1658, 1544, 1346 indicative of 
aromatic C-H, amide C = O and nitro groups, respectively; 
SSA 230 m2g–1.
Instrumentation for characterization of 
reaction products
Nuclear magnetic resonance (NMR)
Proton NMR spectra were recorded on a Varian 300 MHz 
spectrometer at 25 °C on solutions of donor, acceptor, and 
of donor-acceptor mixtures following published procedures 
(Hanna and Ashbaugh 1964; Foster and Fyfe 1965; Dust 
1992; Fesik et al 2000). Typically, 1.75 × 10–5 moles of 
acceptor and sixty times that of donor were dissolved in 
1 mL of deuterated solvent, chloroform-d (unless otherwise 
speciﬁ  ed), in a small test tube and transferred quantitatively 
by pipette to the NMR tube. Experiments meant to provide 
binding constants were run with constant acceptor con-
centration (same as above) and the concentration of donor 
varied such that acceptor to donor ratios ranged from 1:40 
to 1:80.
Ultraviolet-visible spectroscopy (UV-vis)
UV-visible spectroscopic measurements were made on a 
Hewlett Packard 8452A Diode Array Spectrophotometer. 
These measurements were made in a similar fashion to the 
NMR experiments in that the acceptor concentration was 
kept constant while varying the excess concentration of the 
donor. Typically, 3.5 mL of solvent (or mixture) was run as 
background for the acceptor in a 1 cm quartz cuvette. An 
aliquot containing the desired number of moles of the accep-
tor (typically 1 × 10–5) was then pipetted from a stock solution 
into the cuvette and mixed thoroughly and rerun to obtain the 
spectrum for the acceptor. Next, a 3.5 mL solution containing 
the desired excess moles of donor was run as background 
for the complex in order that the excess donor did not obscure 
the spectrum of the complex. An aliquot of the acceptor from 
the standard solution, containing the predetermined number 
of moles was then added to the donor solution, thoroughly 
mixed and its spectrum obtained.
Infrared spectroscopy (IR)
Silica samples were prepared as KBr pellets and examined 
using a Nicolet Magna 760 spectrometer.
High performance liquid chromatography (HPLC)
In a typical experiment to measure BPC uptake from a liquid 
(Varshney et al 2004), 1.5% w/v of SiDNB was placed in a 
phosphate buffer at pH 7.4 containing a known concentra-
tion of BPC hydrochloride. The mixture was shaken for 
30 minutes at room temperature and then ultraﬁ  ltration was 
carried out via the YM-30 centrifree (Millipore) system 
using centrifugation at 3000 rpm for 30 minutes. Several 
10 μL samples of the ﬁ  ltrate were sequentially injected into 
an Alliance (Waters Inc., Milliford, MA) HPLC system. 
The output traces reproducibly indicated less than 5% of 
the original amount of BPC hydrochloride remained in the 
liquid. The same amount of cocaine (COC) hydrochloride 
remained when its solutions were treated with SiDNB. Using 
less SiDNB in more concentrated BPC hydrochloride solu-
tions resulted in proportionately less amount of drug uptake. 
For example, 0.05% w/v SiDNB removed 1800 μM amount 
of drug from a 10,000 μM solution; and, 0.10% w/v SiDNB International Journal of Nanomedicine 2007:2(3) 453
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removed 3800 μM amount. Unmodiﬁ  ed silica showed no 
ability to remove BPC or COC from saline solution.
Results and discussion
Solution measurements
Figure 1 depicts the syntheses and structures of acceptor 
(A) and donor (D) molecules used in this study. The dis-
placement of charge from donor to acceptor that occurs 
in the formation of a π-π complex alters electron density 
thus making the complex amenable to study by nuclear 
magnetic resonance, a technique quite sensitive to small 
changes in the electronic environment of a magnetic 
nucleus. Hanna and Ashbaugh (1964) recognized this fact 
and developed a mathematical expression for use with 
NMR similar to the Benesi-Hildebrand (1949) UV-Vis 
equation to evaluate π-π complexes formed between 
7,7,8,8-tetracyanoquinodimethane (TCNQ) and various 
aromatic donors. For the equation to be valid requires that 
the donor: acceptor concentration ratio be large (eg, 20). 
Plotting the inverse of observed upfield shift in acceptor 
Ar X +  R Y Ar Z R
O2N
O2N
O2N
O2N
NO2
NH2
NH2
NH2
NH2
NH2
NO2
F
F F
F F
Compound Ar X YR
DNB (A)
EDNB (A)
EDNS (A)
MPFB (A)
COCl CH3
COCl
SO2Cl SO2NH CH3CH2
CH3CH2
CH3
CH3
DMAc (D) COCl
COCl
Z
CONH
CONH
NHCO
CONH
CH3
CH3
Figure 1 Synthesis and structures of acceptor (A) and donor (D) molecules studied.International Journal of Nanomedicine 2007:2(3) 454
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resonances compared to the values before addition of 
the donor, versus the inverse of the donor concentration, 
yields an intercept and slope for calculation of an equi-
librium quotient, from which a binding energy for the 
acceptor-donor complex in question can be obtained.
It was deemed pertinent to repeat Dust’s work using 
3,4-dimethoxytoluene as the donor to ascertain our experi-
mental accuracy. The three equivalent aromatic protons of 
1,3,5-trinitrobenzene (TNB) appear as a sharp singlet and from 
an average of ﬁ  ve measurements occur at 9.3856 (±0.0022) 
ppm in CDCl3, which is outside the range of absorption for 
the solvent (7.2540 ppm) and the donors used, thus satis-
fying the requirements set forth by Hanna and Ashbaugh 
(1964). Addition of an excess of 3,4-dimethoxytoluene 
(ratio of acceptor to donor = 1:60) to the solution of TNB 
caused the TNB proton singlet to shift upﬁ  eld by 0.187 ppm. 
Dust obtained a value of 0.183 ppm with the addition of 
N,N-dimethyl-3,4-dimethoxyphenylethylamine. These values 
indicate that Dust’s experiment was satisfactorily reproduced 
in our laboratory.
The upﬁ  eld chemical shift for acceptor nuclei results from 
the ring current effect between both aromatic rings, suggest-
ing the existence of ring stacking interactions (Ishida et al 
1984; Hunter et al 2001). The transfer of charge from the 
donor to the acceptor results in an increase in the π-electron 
density of the latter leading to an increase in shielding of its 
aromatic protons and thus to the observation of an upﬁ  eld 
shift. It is to be noted that the observed resonance of the 
acceptor in the complexing medium is an average between 
free acceptor and that bound in the complex, the protons in 
each of which have a characteristic precessional frequency 
(Sahai et al 1974), since the complex formation is an equi-
librium process.
The electron donating aromatic portion of bupivacaine 
is an amide analog of 2,6-dimethylaniline. Thus, the NMR 
spectra were collected for separate mixtures of TNB with 
each of three isomers, 2,4-, 3,5-, and 2,6-dimethylaniline. 
The observed upﬁ  eld changes in the chemical shifts were 
0.3086 ppm, 0.2647 ppm, and 0.2995 ppm, respectively. 
The greater change in the chemical shifts observed for the 
substituted aniline isomers compared with dimethoxytoluene 
can be accounted for in terms of the difference between the 
electron-donating ability of -NH2 and -OCH3. The former 
substituent is strongly electron donating whereas the latter 
is only moderately so (Hansen 1962).
The next step in the investigation involved the use of 
aromatic acceptor molecules with a unit for attachment to 
nanoparticles in the subsequent stage of the planned toxin 
remediation study. The ﬁ  rst acceptor molecule investigated 
was N-methyl-3,5-dinitrobenzamide (DNB) which exhibits 
proton area 1 doublet and area 2 triplet resonance lines at 
8.9602, 8.9675 ppm, and 9.1680, 9.1745, and 9.1818 ppm, 
respectively. The addition of the donor caused an upﬁ  eld shift 
in each of the resonance lines such that the new resonances 
appear at 8.9245, 8.9309 ppm and 8.9684, 8.9748, and 
8.9822 ppm. The resonance lines of each multiplet were 
averaged to give a single value for each. Thus, the observed 
changes in the chemical shifts were calculated to be 
(doublet) = 0.0412 ppm and (triplet) = 0.1997 ppm.
These results not only demonstrate the upﬁ  eld shift of the 
resonances but show also that the triplet undergoes a greater 
change than the doublet. This can be understood in terms of 
the positions occupied by the protons relative to the electron 
withdrawing groups in the acceptor molecule, and the realiza-
tion that the stacking of one ring over another may not be 
perfectly vertical (Dewar and Lepley 1961). Figure 2 depicts 
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Figure 2 Depiction of electron ﬂ  ow from 2,6-dimethylacetanilide to the aromatic region containing the electron withdrawing nitro groups of 3,5-dinitrobenzamide in the 
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the structures of the components and the ﬂ  ow of electron 
density as the complex is formed between them. Proton a is 
ﬂ  anked by the two most electron withdrawing (nitro) groups 
and come into resonance (triplet) at lower magnetic ﬁ  eld 
strength than proton b (doublet) (a downﬁ  eld from b) as is 
observed in the NMR spectrum. This is so since there is less 
electron density about proton a, as it is diminished there by 
two neighboring strong electron-withdrawing groups, than 
about proton b. As electrons are donated to the acceptor 
(shown by curved arrow), they will be received more so 
around a than around b since the former is more electron 
deﬁ  cient. Upon complex formation, proton a becomes more 
shielded than b due to the donated electrons, and its resonance 
shifts upﬁ  eld to a greater extent.
When complexed with 2,6-dimethylaniline in CDCl3, 
the doublet and triplet of DNB underwent upﬁ  eld shifts of 
0.0779 and 0.0874 ppm, respectively. When the donor was 
the often-overdosed bupivacaine in its free base form, val-
ues of 0.0662 ppm (doublet) and 0.2513 ppm (triplet) were 
obtained. The free base form of bupivacaine was generated 
by stirring 1.0 g of the hydrochloride salt in 9.45 mL of 
0.326M NaOH then extracting with ﬁ  ve 10 mL portions of 
methylene chloride. It was of interest to determine the forma-
tion of a π-π complex between therapeutically administered 
bupivacaine hydrochloride and the acceptor in an aqueous 
medium. The hydrochloride salt of bupivacaine readily dis-
solved in water but the acceptor employed in this study did 
not. Therefore, the formation of the complex was carried 
out in a 50/50 mixture of D2O and CD3CN. In this solvent 
system, DNB upﬁ  eld shift values of 0.0275 ppm (doublet) 
and 0.0891 ppm (triplet) were observed. The lower values 
obtained in the more polar solvent system can be explained 
in terms of a stronger interaction of the ionic donor with 
this solvent and a weaker interaction of the organic acceptor 
with this solvent, thereby limiting the interaction between 
the two solutes and diminishing charge transfer complex 
formation between them.
The protons on two other nitroaromatic acceptors, 
N-ethyl-2,4-dinitrobenzamide and N-ethyl-2,4-dinitroben-
zenesulfonamide underwent the same upﬁ  eld shifts when 
complexed with 2,6-dimethylaniline in chloroform-d. How-
ever, only the chemical shifts due to the π-π interaction with 
the benzamide could be determined when the donor was 
bupivacaine. The aromatic resonance of the sulfonamide was 
overlapped by that of bupivacaine and could not be resolved. 
Three magnetically inequivalent protons exist in both these 
acceptor molecules and Table 1 shows the chemical shifts 
upon complexation.
Further variety in the structure of the π-electron receptor 
was provided by study with tricyanobenzene (TCB), and 
1,3-bis(triﬂ  uoromethyl)benzene, which are possibly more 
biologically friendly receptors than those of the nitro type. 
With 2,6-dimethylaniline, an upﬁ  eld shift of 0.1699 ppm was 
observed for the aromatic singlet of TCB. Measurements 
with 1,3-bis(triﬂ  uoromethyl)benzene with the donor DMAc 
in a molar ratio of 1:20 resulted in an average upﬁ  eld shift 
for the acceptor proton-2 resonance signal of 0.0049 ppm. 
Fluorine NMR resonance shifts of N-methylpentaﬂ  uoro-
benzamide before and after complexation with DMAc were 
from ppm values of –140.2859, –150.4915, and –159.8655 
to –140.6222, –152.1669, and 160.8225, respectively, 
giving the respective shifts of 0.3363 ppm, 1.6754 ppm, and 
0.9570 ppm. These results were encouraging in that they 
demonstrated the feasibility of formulating a toxin recep-
tor containing a more biocompatible group than the nitro 
group. As pointed out in a recent review on interactions with 
aromatic systems in chemical and biological recognition, 
ﬂ  uorine-containing compounds have enjoyed a rich history 
in bioorganic and medicinal chemistry (Meyer et al 2003; 
Thayer 2006). Fluorine has been widely studied in these 
disciplines as a result of its diverse functions, ranging from 
an isosteric and isoelectronic replacement of the hydroxy 
group, to a means of enhancing the metabolic stability of 
drugs and modifying electronic and physical properties (for 
example, lipophilicity, acidity, and steric hindrance).
The experimental evaluation of formation constants for 
π-π charge transfer complexes has often proved troublesome. 
The UV-vis absorption band of the complex might not be 
observed if it occurs in a region of intense absorption by 
the uncomplexed molecular partners or in cases where the 
extinction coefﬁ  cient of the charge transfer transitions are 
much weaker than those of the molecular electronic absorp-
tion. Additionally, even though McConnell and coworkers 
(Landauer and McConnell 1952; Lawrey and McConnell 
1952) suggested as early as 1952 that complexes with 
Table 1 Observed changes in the chemical shifts of N-ethyl-2,4-
dinitrobenzamide and N-ethyl-2,4-dinitrobenzenesulfonamide 
when complexed with 2,6-dimethylaniline (DMA) and bupiva-
caine (BPC) in chloroform-d
Donor  Observed chemical shift changes (ppm)
 Benzamide    Sulfonamide
  H3 H5 H6 H3 H5 H6
DMA  0.2496 0.3242 0.3663 0.2252 0.3014 0.2514
BPC  0.3531 0.3686 0.2903 -  -  -International Journal of Nanomedicine 2007:2(3) 456
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stoichiometries other than 1:1 might coexist in equilibrium 
with the AD complex, most analyses have been made in lieu 
of that possibility. Although evidence has been presented that 
for some donor-acceptor systems higher-order complexes 
do indeed exist (Deranleau 1969a), for most complexes the 
stoichiometry is 1:1.
The voluminous reports on charge transfer transitions 
testify to the ability to experimentally determine the thermo-
dynamic properties associated with these processes. Person 
(1965), in giving a critical discussion of the problem, has 
emphasized that the most accurate values for binding con-
stants of a complex are obtained when the equilibrium con-
centration of the complex is of the same order of magnitude as 
the equilibrium concentration of the more dilute component. 
Such condition can be approximated when the ratio of donor 
to acceptor is large. Deranleau (1969a; 1969b) has discussed 
considerations that must be given to some aspects of the 
measurement of formation constants from the standpoint of 
basic binding theory. He has pinpointed various sources of 
error and suggested criteria for the reliability of formation 
constants and extinction coefﬁ  cients obtained from the usual 
methods of treatment of weak molecular complexes.
We carried out NMR experiments following methods in 
the literature (Hanna and Ashbaugh 1964; Foster and Fyfe 
1965; Fesik et al 2000) to determine the binding constants 
for the π-π complexes formed in this study. These methods 
involve keeping the concentration of the acceptor constant 
while varying that of the donor, which is always kept in 
excess, for example, 1:40, 1:50, 1:70, 1:70, and 1:80. The 
values of the reciprocal of the upﬁ  eld shift in resonance of 
protons on acceptor molecules were then plotted against 
the reciprocal of the donor concentration. An example is 
shown in Figure 3. Similar plots for DNB (H4) complexed 
with DMA and of EDNB(H3) with DMA yielded R2 values 
of 0.9922 and 0.9776, respectively. Calculations using the 
slopes and intercepts of the plotted linear lines yielded the 
K values shown in Table 2, and hence the ΔG values. A set 
of ﬁ  ve measurements with N-methyl-3,5-dinitrobenzamide 
demonstrates the error associated with measuring the chemi-
cal shift changes with a standard deviation of 0.0039 ppm, 
which is associated with the calculated binding constants.
Only bupivacaine appears to form the complex exother-
mally. Bupivacaine has a large hydrophobic nonaromatic 
portion that may contribute to a favorable interaction with 
the hydrophobic receptor molecule. The negative value of ΔG 
obtained with this molecule is consistent with thermodynamic 
quantities characteristic for binding driven by both π-π and 
classic hydrophobic effects, namely, a large favorable com-
plexation entropy TΔS and a small complexation enthalpy, 
ΔH (Meyer et al 2003). That the other donors each exhibit a 
positive ΔG indicates that in the free energy expression, the 
enthalpy of complexation is large relative to the entropy term. 
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As indicated by the upﬁ  eld shift observed in these systems, 
complex formation did occur.
The formation of π-π complexes in these systems 
was substantiated by evidence obtained by UV-visible 
spectroscopic measurements. This technique was used to 
obtain information on the formation of complexes formed 
between DNB and DMAc and between DNB and bupivacaine 
hydrochloride (BPCHCl), with an acceptor to donor molar 
ratio of 1:60 in 50/50 water/acetonitrile, Figure 4. In the 
absence of the donor, DNB exhibited a λmax of 278 nm. The 
addition of the donor caused a red shift in the λmax value to 
284 nm. This shift is diagnostic of π-π complex formation. 
Visibly, mixtures of these donors with acceptors appear red-
brown in color due to absorption of green light. However, we 
were not able to observe such long wavelength absorbance 
in our studies (Figure 4).
Dispersion measurements
The goal of this research is to prepare carrier nanoparticles 
for in vivo reversal of overdoses of exemplary molecules 
1 and 4. Encouraged by the positive results from the solution 
measurements, that pi-pi interactions are favorable between 
bupivacaine (1) and dinitrobenzene ring receptors, we 
covalently tethered the latter to silica nanoparticles to obtain 
proof-of-concept data.
Surface attachment of the 3,5-dinitrobenzoyl moiety to 
silica was achieved by reaction with the benzoyl chloride 
reagent by standard procedure. In the present case excess 
reagent was used, veriﬁ  ed by recovery of some in the liquid 
washes of the solid product, hereafter referred to as SiDNB. 
This resulted in attaching the maximum number of pi receptor 
molecules to each particle. Analysis of the solid by TGA and 
IR veriﬁ  ed the desired functionalization had occurred.
SiDNB proved to be very efﬁ  cient in removing both 
bupivacaine (BPC, 1) and cocaine (COC, 4) as hydrochlo-
ride salts from saline. HPLC data collected on solutions of 
each 1 and 4, before and after stirring with sufﬁ  cient SiDNB 
showed that uptake of either of the molecules by the particles 
was over 95% complete within ten minutes. Calculation using 
weight, density and diameter of the particles, and moles 
-0.20
-0.10
0.00
0.10
0.20
0.30
0.40
0.50
Wavelength (nm)
A
b
s
o
r
b
a
n
c
e
DNB
DNB1:BPCHCl60
DNB1:DMAc60
250 300 350 400 450
Figure 4 UV-Vis spectrum of DNB in the absence of donor-unbroken line; in the presence of BPC-dashed line; and in the presence of DMAc-dotted line. Molar ratio 
A:D = 1:60. Solvent, 50/50 water/acetonitrile.
Table 2 Equilibrium constants and free energies of binding
Complex K  (L  ⋅ mol–1)  ∆G (cal/mol)
DNB:DMA 0.4904  419
EDNB:DMA 0.7941  137
EDNB:BPC 1.9558  –395International Journal of Nanomedicine 2007:2(3) 458
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of BPC removed, gave approximately 90 BPC molecules 
bonded to one as-prepared SiDNB particle. Figure 5 shows 
the uptake of BPC using less SiDNB per amount of drug, 
proof that more receptors remove more BPC. The solid 
collected after mixing with the drug-containing solutions, 
SiDNB-BPC, exhibited enhanced TGA weight loss and 
some differences in IR absorbance values compared to 
SiDNB. The present work has established for the ﬁ  rst time 
that toxins 1 and 4, and simple derivatives of 1, efﬁ  ciently 
bind to pi receptor molecules free in solution or attached 
to carrier silica nanoparticles. This served as precedent for 
the study reported by this group (Lee et al 2005), where 
oligochitosan microparticles were similarly functionalized, 
(compare Domszy and Roberts 1985). However, if these 
chemical antidotes are to be ultimately employed for internal 
overdose treatment, their in vivo effect on blood cells and 
organs must ﬁ  rst be evaluated. Towards that goal, an isolated 
guinea pig heart did not exhibit irregular function or damage 
when exposed to a saline solution of BPC hydrochloride 
complexed with DNB.
Also of concern is the stability to hydrolysis of the ester 
linkage bonding the dinitrobenzoyl moiety to the silica par-
ticle. Two fundamental organic chemical principles oppose 
each other in this regard. Nitro groups on the aromatic rings 
of alkyl benzoate esters are known to enhance hydrolysis in 
both acidic and basic media (Palm 1957, 1990). However, the 
rate and yield of hydrolysis drops signiﬁ  cantly as the size of 
the alkyl group increases. For example, the rate of hydrolysis 
of tertiary butyl benzoate at 40 οC is less than half that of 
methyl benzoate at 25 οC. We have not measured the rate of 
hydrolytic formation of 3,5-dinitrobenzoic acid from SiDNB 
but suggest that it will be nil at physiologic conditions due to 
the massive size of the silica particle to which the precursor 
is attached. This should ensure that nitroaromatics would 
not become free molecular species in blood and add to the 
toxicity already due to overdosed 1 and 4.
Conclusion
The original goal of this research was to demonstrate the 
formation of charge transfer (π-π) complex between the 
important but toxic local anesthetic bupivacaine, a π-electron 
rich aromatic molecule, and an electron deﬁ  cient aromatic 
acceptor molecule. This was done in order to establish a 
proof of concept that the charge transfer phenomenon could 
be utilized for the removal of the overdosed toxin by attach-
ing the receptor to nanoparticles. By utilizing proton NMR 
spectroscopy primarily, π-π complexes were shown to form 
in solution, ﬁ  rst between models of bupivacaine and several 
acceptors, and then between bupivacaine and the dinitroben-
zoyl acceptors. The formation of complex was substantiated 
by UV-visible spectroscopy. The binding energy for bupi-
vacaine complexed with N-ethyl-2,4-dinitrobenzamide was 
found to be exothermic with a value of ΔG = –395 cal ⋅ mol–1 
from a binding constant of 1.9558 L ⋅ mol–1 determined from 
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the NMR data. This research has shown that the concept of 
π-π complex formation is a viable method for the devel-
opment of injectable antidotes for in vivo deployment for 
the remediation as of overdoses of bupivacaine and other 
chemical toxins.
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